Experimental rupture of atherosclerotic lesions increases distal vascular resistance: A limiting factor to the success of infarct angioplasty

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 1, 2002, Pages 153-160

  Taylor, Andrew J ^a   Bobik, Alex ^a   Berndt, Michael C ^a   Ramsay, Debra ^a   Jennings, Garry ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Atherosclerosis; Blood flow; Plaque rupture; Thrombosis; Vasodilators

Indexed keywords

ADENOSINE; CHOLESTEROL; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RUPTURE; THROMBOEMBOLISM; THROMBOSIS; VASCULAR RESISTANCE; VASOCONSTRICTION;

ADENOSINE; ANIMALS; ARTERIOSCLEROSIS; CAPILLARY PERMEABILITY; HINDLIMB; ILIAC ARTERY; MICROCIRCULATION; MODELS, ANIMAL; MUSCLE, SKELETAL; NITROGLYCERIN; NITROPRUSSIDE; RABBITS; REGIONAL BLOOD FLOW; RUPTURE, SPONTANEOUS; THROMBOSIS; VASCULAR RESISTANCE; VASODILATION;

EID: 0036144922     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0102.101128     Document Type: Article

References (44)

1. Plaque fissuring: The cause of acute myocardial infarction causing sudden ischaemic death, and crescendo angina
2. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association
3. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis: Implications for plaque rupture
4. Increased matrix metalloproteinase-9 activity in unstable coronary carotid plaques: A potential role in acute plaque disruption
5. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2
6. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
7. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
8. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: The Primary Angioplasty in Myocardial Infarction Study Group
9. A two-decades (1975-1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: A community-wide perspective
10. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: New insights using myocardial contrast echocardiography
11. Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction
12. Alteration in the blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction
13. Microvascular compression during myocardial ischaemia: Mechanistic basis for no-reflow phenomenon
14. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: Possible implications for leukocyte aggregation and microvascular plugging
15. Increased catalase levels and hypoxanthine-enhanced nitro-blue tetrazolium staining in rat retina after ischaemia followed by recirculation
16. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin
17. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction
18. 2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase
19. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
20. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction
21. Vascularized heterotopic osteochondral allografts in a rat model following long-term immunosuppression
22. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction
23. Detection of an epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb-IIIa complex and its expression on the surface of adherent platelets
24. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions: Colocalization implicates TGF-beta in fibrofatty lesion development
25. Brief myocardial ischemia attenuates platelet thrombosis in remote, damaged, and stenotic carotid arteries
26. Increases of vascular endothelin-converting enzyme activity and endothelin-1 level on atherosclerotic lesions in hyperlipidaemic rabbits
27. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina
28. Endothelin-1 release from atherosclerotic plaque after percutaneous transluminal coronary angioplasty in stable angina pectoris and single vessel coronary artery disease
29. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
30. Hypercholesterolaemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
31. Changing concepts of atherogenesis
32. Platelet-derived nitric oxide and coronary risk factors
33. Collateral development and angiogenesis after major artery ligation does not alter hindquarter vascular reactivity in conscious rabbits
34. Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin
35. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: Initial human clinical experience
36. Delayed recovery of coronary resistive vessel function after coronary angioplasty
37. Platelet aggregation in partially obstructed vessels and its elimination with aspirin
38. Restenosis following transluminal angioplasty in experimental atherosclerosis
39. Acute effects of transluminal angioplasty in three experimental models of atherosclerosis
40. Animal model that mimics atherosclerotic plaque rupture
41. Time course of post-ischemic superoxide generation in venous effluent from reperfused rabbit hindlimbs
42. Natural history and histological classification of atherosclerotic lesions: An update
43. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions